introduction
The elderly have an increased susceptibility to infections and impaired responses to vaccination, which may be caused by aging of the immune system, also referred to as immunosenescence. This poses a major challenge to public health, which may become even greater as the percentages of older people increase in the Western population. Various factors such as an impaired innate immune system but also reduced T and B cell responses may contribute to immunosenescence [1] [2] [3] . Longitudinal studies in the aged (>85 years) have suggested that poor immunological responses are associated with an "immune risk profile". Characteristics of this risk profile are an inverted CD4/CD8 ratio and increased numbers of CD27ˉCD28ˉCD57 + effector-type CD8 + T cells 4 . We and others have shown that the presence of large numbers of these CD27ˉCD45RA
+ and CD57 + CD28ˉ CD8 + T cells, which are largely overlapping populations, is associated with latent cytomegalovirus (CMV) infection [5] [6] [7] [8] . Therefore CMV infection may contribute to immunosenescence.
It is generally believed that the size of the CD8 + T cell pool is fixed and that with every new viral challenge the size of the pre-existing memory cell population shrinks to make way for new virus-specific cells, a process referred to as memory cell attrition 9 . However, Vezys et al, have challenged this notion by demonstrating in an elegant murine model system of repetitive antigenic challenge, that the CD8 + T cell compartment is remarkably flexible and has the capacity to expand and accommodate vast numbers of antigen-specific CD8 + T cells 10 . This enlargement predominantly occurs within the effector memory subset and consequently the major enlargements of the CD8 + T cell pool take place in spleen, blood and solid tissues but not in lymph nodes. Importantly, memory CD8 + T cells specific for previously encountered infections were found to be largely preserved. In line with these observations in experimental animal models, we have shown in humans that the entrance of CMV-specific CD8 + T cells expanded the Ag-primed CD8 + T cell compartment rather than competing for "immune-space" with pre-existing memory T cells specific for persistent or cleared viruses 11 . In this respect it is interesting that circulating CMV-specific CD8 + T cells in latent virus carriers do not express CCR7 [12] [13] [14] but have a high expression-level of CX3CR1 15 , the chemokine receptor for fractalkine, a cell-bound chemokine expressed on stressed endothelial cells. Thus, expression of CX3CR1 provides CMV-specific CD8 + T cells with the ability to migrate to inflamed vascular endothelium 16;17 , whereas the absence of CCR7 indicates that these cells are unlikely to home to LN.
To test this notion directly, we questioned whether CMV infection limits immunological space at sites where immune reactions are initiated, such as in LN. We had the unique opportunity to study LN derived human T cells. These cells were isolated from LN gathered from surgical waste material collected during living donor kidney transplantation. We investigated the presence, phenotype and polyfunctionality of CMV-, EBV-, influenza-specific and total CD8 + T cells in the LN and compared this to the PB compartment.
materials and metHods

Subjects
We studied absolute numbers of CD4 + and CD8 + T cells, B-cells and NK-cells in a large group of patients on the waiting list for renal transplantation (n=560). In a smaller group of transplant recipients (n=21) we studied paired heparinized peripheral blood mononuclear cells (PBMC) and lymph node mononuclear cells (LNMC), which were isolated prior to, respectively during kidney transplantation. All these patients were EBV-seropositive and the majority of patients were also CMV-seropositive (16 of 21 patients). All patients were treated with quadruple immunosuppression, consisting of CD25mAb induction therapy, Prednisolone, calcineurin-inhibitor and mycophenolic acid. Except for CD25mAb, immunosuppressive treatment was started after transplantation. At the time the lymph node was gathered the first dose of CD25mAb was already administered. However, we have demonstrated that CD25mAb (basiliximab, Novartis Pharma, Basel, Switzerland) was not detectable in LNMC and that ex vivo CD25 expression on LNMC could be blocked with CD25mAb (supplemental figure 1 ). The medical ethics committee of the Academic Medical Center, Amsterdam, approved the study and all subjects gave written informed consent.
isolation of mononuclear cells from peripheral blood and lymph nodes
PBMCs were isolated using standard density gradient centrifugation. Lymph nodes were collected from kidney transplant recipients during living donor kidney transplantation. Briefly, LNMCs were isolated from surgical residual material of the recipient, gathered during the implantation of the transplanted kidney. Before anastomising the arteria and vena renalis, the iliac artery and vein are dissected free. The residual tissue removed in this procedure, to obtain adequate vascular exposure, often contains lymph nodes. Directly after extraction, the gathered lymph nodes were chopped in small pieces. A cell suspension was obtained by grinding the material through a flow-through chamber. PBMCs and LNMCs were subsequently cryopreserved until the day of analysis. 38 , PBMCs and LNMCs were thawed and rested overnight in suspension flasks (Greiner) in RPMI supplemented with 10% FCS, penicilline and streptomycine (culture medium). Two million cells were stimulated with PMA/ Ionomycin or with the viral peptides in culture medium in the presence of CD107a FITC (eBioscience), αCD28 (15E8) (2μg/ml), αCD29 (TS 2/16) (1 μg/ml), brefeldin A (Invitrogen Ltd) (10μg/ml) and Golgistop (BD) in a final volume of 200ul, for 4 hours (PMA (10ng/ml)/Ionomycin(1μg/ml)) or 6 hours (peptide) at 37ºC 5% CO2. Stimulations were performed in non-treated round bottom 96-well plates (Corning). Subsequently, cells were incubated with the appropriate tetramers followed by incubation with CD3 V500, CD8 V450, CD4 PE-Cy5.5 and Live/Dead fixable red cell stain for 30 min at 4ºC. 
Statistical analysis
Statistical analysis of paired samples was done by two tailed Wilcoxon signed rank test with a 95% confidence interval. Non-paired samples were analyzed with two tailed Mann-Whitney test with a 95% confidence interval. 
results
Cmv leaves a fingerprint in the pb Cd8 + t cell compartment.
Since CMV has been shown to have a large impact on the composition of the PB CD8 + T cell compartment 5 we first studied its influence on the total number of CD8 + T cells in PB. In a large cohort of 560 patients awaiting kidney transplantation, we found nearly twice as many circulating CD8 + T cell numbers in 430 CMV-seropositive individuals compared to 130 CMV-seronegative ones (0,432x10 9 /l versus 0,277x10 9 /l; p<0.0001, figure 1A ). CD4 + T cells, NK cells and B cells were not affected (figure 1B-D respectively). Even in healthy individuals up to 40% of the total CD8 + T cell compartment can be directed against one single peptide-HLA complex ( figure 1E ). These findings establish that CMV infection induces a lasting and profound CD8 + T cell expansion in the PB compartment.
Cmv-specific Cd8
+ t cells are much less dominant in ln than in pb, but percentages of ebv-and flu-specific Cd8 + t cells are similar.
To investigate whether the CMV-specific CD8 + T cells in LN were as abundant as in PB, we compared the percentage of CMV-specific cells in PB CD8
+ T cells to those in LN CD8 + T cells (figure 2). As a control, EBV-and influenza-specific (FLU-specific) CD8 + T cells were enumerated. CMV-specific CD8 + T cells were always found at significantly lower percentages in the LN than in the PB compartment. The presence of EBV-and FLU-specific CD8 + T cells in PB however was similar to those found in LN (figure 2B). Moreover, where CMV-specific CD8 + T cells exceeded EBV specific CD8 + T cells in PB, in LN this was found to be quite the opposite (figure 2C). Thus, in the LN, CMV-specific CD8 + T cells are only a minority of the total CD8 + T cell population.
Cmv-specific Cd8 + t cells as well as total Cd8 + t cells in ln are enriched for CCr7 and CXCr3 and almost depleted of CX3Cr1 expressing cells.
To understand why LN CD8
+ T cells contained dramatically less CMV-specific CD8 + T cells, we studied chemokine receptor expression. One of the chemokines expressed abundantly on PB CMV-specific CD8 + T cells is CX3CR1 15 . CX3CR1 allows for homing to inflamed endothelium and tissue via its ligand fraktalkine. The amount of cells expressing CX3CR1 in total CD8 + T cells as well as in CMV-and EBV-specific CD8 + T cells in LN was strongly reduced when compared to PB (p=0.001, P<0.005, P<0.001 respectively figure 3B), suggesting exclusion from the LN. We hardly found any CX3CR1 expressing FLU-specific cells, neither in the PB nor in the LN. Since CCR7 is required for the homing to resting LN, we next investigated the expression of this receptor. As expected, more CCR7 expressing total CD8 + T cells were found in LN (P=0.0001, figure 3C ). Also CMV-specific CD8 + T cells were highly enriched for CCR7 expressing cells (p<0.0005). A similar trend was observed for FLU-specific CD8 + T cells, but not for EBV-specific CD8 + T cells. In mice, CXCR3 has been shown to be involved in the recruitment of T cells towards draining lymph nodes 18 . Both total CD8 + T cells as well as CMV-and EBV-specific CD8 T cells in LN were enriched for CXCR3 expressing cells. Strikingly LN CMV-specific CD8 + T cells resembled LN EBV-specific CD8 + T cells in respect to all chemokine receptors studied. Equal high percentages of FLU-specific cells in PB and LN express CXCR3. Together, these data suggest that the lower percentages of CMV-specific CD8 + T cells found in the LN might be caused by the exclusion of the CX3CR1-positive CMV-specific CD8 + T cells, the major phenotype in PB, and the recruitment of CCR7 expressing CMV-specific CD8 + T cells into the LN, the phenotype that is hardly found in PB.
total Cd8
+ t cells as well as Cmv-specific Cd8 + t cells in ln contain less Cd45ra + Cd27ˉ effector-type cells.
The difference in expression of chemokine receptors between the PB and LN CMV-specific CD8 + T cells prompted us to further investigate other phenotypical differences. Since most CMV-specific cells in PB are CD45RA + CD27ˉ, markers previously shown to depict an effector phenotype, we studied the LN CMV-specific CD8 + T cells for their expression of these markers (figure 4). Already when analyzing the total CD8 + T cell compartment the lack of effector type cells in the LN became apparent. The difference between the PB and LN CD8 + T cells was highly significant (p=0.0001, figure 4B ). This finding was reflected in the lower percentage of effector-type cells in LN CMV-and EBV-specific CD8 + T cells (both p<0.005) compared to PB. Since hardly any PB FLU-specific CD8 + T cells with an effector phenotype could be detected, the difference between PB and LN was not significant. In short, a substantially greater part of the LN total CD8 + T cells as well as CMV-and EBVspecific CD8
+ T cells displayed a memory phenotype when compared to PB.
only few granzyme b + granzyme Kˉ Cmv-and ebv-specific Cd8 + t cells as well as total Cd8 + t cells are found in ln.
We next assessed whether LN CMV-specific CD8 + T cells, besides differences in abundance, homing potential en effector phenotype, also differed in function. Therefore the cytolytic capacity of the LN CMV-specific CD8 + T cells by analyzing granzymes was studied. In PB the majority of the CMV-specific CD8 + T cells contained vast amounts of granzyme B. PB EBV-specific CD8 + T cells however usually contained granzyme K instead (figure 5). In LN the percentage of granzyme B containing CD8 + T cells was significantly lower than the PB CD8 + T cells (P=0.001, figure 5B ). This was also the case, albeit to a lower extent, for LN CMV-specific CD8 + T cells (P<0.01). LN EBV-and FLU-specific CD8 + T cells consisted of equal amounts of granzyme B containing cells compared to PB. For granzyme K no differences between CD8 + T cells from LN and PB were seen. The LN CMV-and EBV-specific CD8 + T cells however did comprise more granzyme K positive cells than the PB CMV-and EBV-specific CD8 + T cells (P<0.005 and p<0.001, figure 5C ). FLU-specific CD8 + T cell populations in LN showed a tendency towards less granzyme B and K containing cells. Most striking however less granzyme B + granzyme K -cells were found in all LN (virus specific) CD8 + populations studied (except for the FLU-specific cells, which do not contain detectable amounts of these cells even in PB) (CD8 P=0.001, CMV P<0.005, EBV P<0.0005). In summary, also when regarding cytolytic function, LN derived CMV-and EBVspecific as well as total CD8 + T cells contain less effector-type cells.
more polyfunctional Cmv-specific Cd8 + t cells are found in ln
To analyze cytokine secretion capacity, CMV-specific CD8 + T cells were stimulated with their cognate peptides. Strikingly, LN CMV-specific CD8 + T cells needed less peptide to induce the production of IL-2 and a larger percentage of all LN CMV-specific CD8+ T cells were capable of producing IL-2 (figures 6A). The production of TNFα, IFNγ, MIP-1β and the expression of CD107a were similar in LN and PB CMV-specific CD8+ T cells. Remarkably, the percentage of polyfunctional cells (producing all 4 cytokines and expressing CD107a) was almost solely dependent on the percentage of IL-2- Cmv does not leave a fingerprint in the ln Cd8 + t cell compartment.
Finally we studied the impact of CMV on the LN total CD8 + T cell compartment.
When we compared the subsets that, in PB, are associated with CMV seropositivity (CD45RA + CD27ˉ; CX3CR1 + CCR7ˉ and granzyme B + granzyme Kˉ), we observed no apparent differences when comparing LN from CMV seronegative individuals to LN from seropositive ones ( figure 7 ). Thus as a result of the minute amounts of CMVspecific CD8 + T cells in LN and their resemblance, in both phenotype and function, to memory CD8 + T cells, CMV seropositivity does not leave a clear imprint in the total CD8 + T cell compartment of the LN.
discussion
Latent CMV infection is characterized by the presence of large numbers of circulating CMV-specific CD8 + T cells. We and others previously showed that expansion of the CD8 + T cell pool occurring during primary CMV infection does not affect absolute numbers of pre-existing memory CD8 + T cells directed against other persistent (e.g.
Epstein Barr) or cleared (influenza) viruses 6;11;19 . Together, this indicates that the expansion of CMV-specific CD8 + T cells found in the peripheral blood compartment do not displace memory CD8 + T cells with other viral specificities, but rather enlarges the total CD8 + T cell pool. These findings are in agreement with the earlier mentioned study in mice, demonstrating enlargement of the CD8 + T cell pool after repetitive antigen challenge 10 . Murine naïve T cells and also central memory T cells, expressing CCR7 and L-selectin are known to continuously re-circulate through LN, where they can encounter antigen and rapidly give rise to effector T cells 20 30 or replicative senescence of primed memory T cells. However, these factors can not entirely explain the earlier mentioned concept of the "immune risk profile" in older people which has been associated specifically with CMV 31 . Previously, we have shown that CMV induces a sustained chronic inflammation apparent from increased serum levels of IFNγ and CRP 32 . In addition to being a very potent activator of the immune system, IFNγ has been reported to exert suppressive actions, such as inhibition of human T cell responses 33 .
In a CD70TG sustained co-stimulation mouse model, IFNγ has been shown to induce B cell depletion in bone marrow, spleen and lymph nodes. Over-expression of CD70 leads to T cell differentiation toward an effector-phenotype (CD27 -) 34 . Human CMVseropositive individuals likewise have consistently more circulating CD27ˉ effectortype CD8 + T cells and higher serum levels of IFNγ compared to CMV-seronegative ones. However, we did not observe a lower absolute number of circulating B cells. Possibly, B cells are depleted from other lymphoid compartments as demonstrated in the above mentioned mouse study. Furthermore, CMV is famous for having a large amount of proteins that subvert immune surveillance in the host 28 . One example is the viral IL-10 (hcmvIL-10) ortholog 35 , which is able to bind to the human IL-10 receptor 36 and can inhibit both innate and adaptive immune responses 37 . Possibly, hcmvIL-10 can also more systemically affect innate and adaptive immune responses directed against other infections. In summary, we found that large numbers of CMV-specific CD8 + T cells, generated during latent infection, increase the total CD8 + T cell pool without affecting other virus-specific CD8 + T cells in the PB. Furthermore, we demonstrate that CMV-specific CD8 + T cells are hardly present in the LN and thus do not limit immunological space 
